Synthetic Biologics Launches Free Investor Relations Mobile ApplicationSynthetic Biologics Inc. (NYSE Amex: SYN) Thursday announced the release of its investor relations mobile iPhone App, called the "SYN IR" App, now available for free at the Apple App Store on the iPhone or iPad or at http://bit.ly/I9xDpW.
Adeona Names New Managers, Eyes Name ChangeAdeona Pharmaceuticals Inc. has swapped bosses as it continues testing new drugs for multiple sclerosis, fibromyalgia and Lou Gehrig's disease. It's also considering a new business focus and a name change.
Adeona Loss Grows, But Milestones ReachedAnn Arbor-based Adeona Pharmaceuticals Inc. (AMEX: AEN), a developer of medicines for serious central nervous system diseases, Monday reported its second quarter financial results for the period ended June 30, as well as updates since the beginning of the second quarter.
Wayne State Prof Gets $3.4M From NIH For Fibromyalgia Research